Ad is loading...
TIERX
Price
$8.10
Change
-$0.05 (-0.61%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

TIERX vs VTSNX

Header iconTIERX vs VTSNX Comparison
Open Charts TIERX vs VTSNXBanner chart's image
Nuveen International Eq A
Price$8.10
Change-$0.05 (-0.61%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
TIERX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TIERX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TIERX is a Buy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. TIERX (6.47B). TIERX pays higher dividends than VTSNX: TIERX (3.83) vs VTSNX (3.29). TIERX was incepted earlier than VTSNX: TIERX (19 years) vs VTSNX (14 years). TIERX is a more actively managed with annual turnover of: 19.00 vs. VTSNX (4.00). TIERX has a lower initial minimum investment than VTSNX: TIERX (2500) vs VTSNX (5000000). TIERX (11.19) and VTSNX (10.92) have marching annual gain over last year. TIERX return over 5 years is better than : 27.91 vs. VTSNX (15.91).
TIERXVTSNXTIERX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years14 years-
Gain YTD4.6514.535103%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.47B442B1%
Annual Yield % from dividends3.833.29116%
Returns for 1 year11.1910.92103%
Returns for 3 years-4.53-5.8677%
Returns for 5 years27.9115.91175%
Returns for 10 years22.8529.8177%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals